28.10.2011 • News

Majority Stake in CU Chemie Uetikon Sold to Barclays Private Equity

Barclays Private Equity (BPE) has acquired a majority shareholding in CU Chemie Uetikon, a fine chemicals company based in Lahr, Germany.  With a shareholding of 90%, BPE will have a controlling interest in the spin-off from the Swiss group CPH Chemie + Papier Holding AG. Together with management, BPE said it will pursue a consistent growth strategy in pharmaceuticals, cosmetics and nutrition industries. The consideration is undisclosed and completion is subject to regulatory approval.

 

Company

CU Chemie Uetikon

Raiffeisenstr. 4
77933 Lahr
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.